Psychopharmacotherapy of Premenstrual Dysphoric Disorder—New Vistas
Year: 2025
Type: article
Abstract: Nearly forty percent of women with PMDD remain impaired and resistant to first-line agents. This reflects complexity and heterogeneity of etiopathogenesis at the core of PMDD. Some agents, in the pipeline, sound promising that might usher in a new sparkle in the psychopharmacology of PMDD.
Source: Psychopharmacology Bulletin
DOI: 10.64719/pb.4447
Institution: Alexandria University
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4285028396
